Blue Note Therapeutics, Inc. — Form D/A
Blue Note Therapeutics, Inc. of SAN FRANCISCO, CA, a company, filed a Form D amendment with the SEC on 2021-08-24. The offering totals $50.0M, of which $15.5M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2021-08-24
- Form: D/A
- Accession: 0001168404-21-000011
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $50.0M
- Amount sold: $15.5M
- Remaining: $34.5M
- Investors: 4
- Date of first sale: 2021-02-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-389303
Issuer
- Name: Blue Note Therapeutics, Inc.
- CIK: 0001777911
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 548 MARKET ST., #55709, SAN FRANCISCO, CA, 94104
- Phone: 408-669-2789
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Geoffrey Eich | Director | SAN FRANCISCO, CA |
| Andrew Firlik | Director | Rowayton, CT |
| John Harris | Director | Richardson, TX |
| Geoffrey Eich | Executive Officer | SAN FRANCISCO, CA |
Other filings by this issuer (1)
More